D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 76 Citations 18,220 360 World Ranking 14131 National Ranking 7322

Overview

What is he best known for?

The fields of study he is best known for:

  • Cancer
  • Internal medicine
  • Surgery

His primary scientific interests are in Internal medicine, Pancreatic cancer, Oncology, Adenocarcinoma and Surgery. His research ties Gastroenterology and Internal medicine together. Pancreatic cancer is a subfield of Cancer that he investigates.

His Oncology research incorporates elements of Pancreatectomy, Exocrine pancreas, Lymph node and Clinical trial. His research integrates issues of Pancreatic disease, Radiation therapy, Pancreaticoduodenectomy and General surgery in his study of Adenocarcinoma. His work investigates the relationship between Surgery and topics such as Lymphadenectomy that intersect with problems in Primary sclerosing cholangitis, Bile duct, Percutaneous transhepatic cholangiography and Liver transplantation.

His most cited work include:

  • DPC4 Gene Status of the Primary Carcinoma Correlates With Patterns of Failure in Patients With Pancreatic Cancer (743 citations)
  • Recent Progress in Pancreatic Cancer (552 citations)
  • Pancreatic adenocarcinoma, version 2.2017: Clinical practice guidelines in Oncology (453 citations)

What are the main themes of his work throughout his whole career to date?

Joseph M. Herman focuses on Internal medicine, Oncology, Pancreatic cancer, Radiation therapy and Radiology. The various areas that Joseph M. Herman examines in his Internal medicine study include Gastroenterology and Surgery. He studied Oncology and Survival rate that intersect with Surgical oncology.

His biological study spans a wide range of topics, including Pancreatectomy, Pancreas, Disease, Gemcitabine and Chemoradiotherapy. In his study, Image-guided radiation therapy is strongly linked to Nuclear medicine, which falls under the umbrella field of Radiation therapy. His Radiology study integrates concerns from other disciplines, such as Colorectal cancer and Resection.

He most often published in these fields:

  • Internal medicine (45.73%)
  • Oncology (34.35%)
  • Pancreatic cancer (32.82%)

What were the highlights of his more recent work (between 2017-2021)?

  • Pancreatic cancer (32.82%)
  • Radiology (22.32%)
  • Radiation therapy (25.60%)

In recent papers he was focusing on the following fields of study:

His main research concerns Pancreatic cancer, Radiology, Radiation therapy, Internal medicine and Cancer. His Pancreatic cancer research integrates issues from Stereotactic body radiation therapy, Clinical trial, Gemcitabine, Chemotherapy and Pancreatectomy. His Radiation therapy research includes elements of Stage and Proportional hazards model.

His Internal medicine study combines topics in areas such as Gastroenterology and Oncology. Joseph M. Herman has researched Gastroenterology in several fields, including Hepatocellular carcinoma, Lymphocyte and Adenocarcinoma. The Cancer study combines topics in areas such as Radiation oncology, Medical physics and Family medicine.

Between 2017 and 2021, his most popular works were:

  • Circulating Nucleic Acids Are Associated With Outcomes of Patients With Pancreatic Cancer (109 citations)
  • Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer (85 citations)
  • Is a Pathological Complete Response Following Neoadjuvant Chemoradiation Associated With Prolonged Survival in Patients With Pancreatic Cancer (64 citations)

In his most recent research, the most cited papers focused on:

  • Cancer
  • Internal medicine
  • Surgery

His primary scientific interests are in Pancreatic cancer, Internal medicine, Radiology, Radiation therapy and Pancreatectomy. His Pancreatic cancer study incorporates themes from Regimen, Surgery, Physical therapy, Adjuvant therapy and Patient experience. His work carried out in the field of Internal medicine brings together such families of science as Gastroenterology and Oncology.

His Radiology research incorporates themes from Chemotherapy and MEDLINE. In general Radiation therapy study, his work on Particle therapy often relates to the realm of Steering committee, thereby connecting several areas of interest. His work deals with themes such as Cancer and Retrospective cohort study, which intersect with Pancreatectomy.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

DPC4 Gene Status of the Primary Carcinoma Correlates With Patterns of Failure in Patients With Pancreatic Cancer

Christine A. Iacobuzio-Donahue;Baojin Fu;Shinichi Yachida;Mingde Luo.
Journal of Clinical Oncology (2009)

1049 Citations

Recent Progress in Pancreatic Cancer

Christopher L. Wolfgang;Joseph M. Herman;Daniel A. Laheru;Alison P. Klein.
CA: A Cancer Journal for Clinicians (2013)

921 Citations

Pancreatic adenocarcinoma, version 2.2017: Clinical practice guidelines in Oncology

Margaret A. Tempero;Mokenge P. Malafa;Mahmoud Al-Hawary;Horacio Asbun.
Journal of The National Comprehensive Cancer Network (2017)

804 Citations

Impact of Sarcopenia on Outcomes Following Resection of Pancreatic Adenocarcinoma

Peter Peng;Omar Hyder;Amin Firoozmand;Peter Kneuertz.
Journal of Gastrointestinal Surgery (2012)

465 Citations

Computational Modeling of Pancreatic Cancer Reveals Kinetics of Metastasis Suggesting Optimum Treatment Strategies

Hiroshi Haeno;Mithat Gonen;Meghan B. Davis;Joseph M. Herman.
Cell (2012)

427 Citations

Preoperative Modified FOLFIRINOX Treatment Followed by Capecitabine-Based Chemoradiation for Borderline Resectable Pancreatic Cancer: Alliance for Clinical Trials in Oncology Trial A021101.

Matthew H.G. Katz;Qian Shi;Syed A. Ahmad;Joseph M. Herman.
JAMA Surgery (2016)

421 Citations

Phase 2 multi-institutional trial evaluating gemcitabine and stereotactic body radiotherapy for patients with locally advanced unresectable pancreatic adenocarcinoma

Joseph M. Herman;Daniel T. Chang;Karyn A. Goodman;Avani S. Dholakia.
Cancer (2015)

402 Citations

Impact of Total Lymph Node Count and Lymph Node Ratio on Staging and Survival after Pancreatectomy for Pancreatic Adenocarcinoma: A Large, Population-Based Analysis

Mark B. Slidell;David C. Chang;John L. Cameron;Christopher Wolfgang.
Annals of Surgical Oncology (2008)

398 Citations

SMAD4 Gene Mutations Are Associated with Poor Prognosis in Pancreatic Cancer

Amanda Blackford;Oscar K. Serrano;Christopher L. Wolfgang;Giovanni Parmigiani.
Clinical Cancer Research (2009)

378 Citations

Pancreatic Adenocarcinoma, Version 2.2014

Margaret A. Tempero;Mokenge P. Malafa;Stephen W. Behrman;Al B. Benson.
Journal of The National Comprehensive Cancer Network (2014)

359 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Joseph M. Herman

Timothy M. Pawlik

Timothy M. Pawlik

The Ohio State University Wexner Medical Center

Publications: 211

Christopher L. Wolfgang

Christopher L. Wolfgang

New York University

Publications: 129

Ralph H. Hruban

Ralph H. Hruban

Johns Hopkins University School of Medicine

Publications: 110

Claudio Bassi

Claudio Bassi

University of Verona

Publications: 62

Marc G. Besselink

Marc G. Besselink

University of Amsterdam

Publications: 60

Carlos Fernandez-del Castillo

Carlos Fernandez-del Castillo

Harvard University

Publications: 59

Michael Goggins

Michael Goggins

Johns Hopkins University

Publications: 56

Herbert J. Zeh

Herbert J. Zeh

The University of Texas Southwestern Medical Center

Publications: 55

Jason B. Fleming

Jason B. Fleming

The University of Texas MD Anderson Cancer Center

Publications: 54

Markus W. Büchler

Markus W. Büchler

University Hospital Heidelberg

Publications: 53

Cristina R. Ferrone

Cristina R. Ferrone

Harvard University

Publications: 50

Douglas B. Evans

Douglas B. Evans

Medical College of Wisconsin

Publications: 47

Eileen M. O’Reilly

Eileen M. O’Reilly

Memorial Sloan Kettering Cancer Center

Publications: 47

Jeffrey E. Lee

Jeffrey E. Lee

The University of Texas MD Anderson Cancer Center

Publications: 47

Keith D. Lillemoe

Keith D. Lillemoe

Harvard University

Publications: 44

Peter J. Allen

Peter J. Allen

Duke University

Publications: 44

Trending Scientists

Barry Z. Posner

Barry Z. Posner

Santa Clara University

Juan Gabriel Brida

Juan Gabriel Brida

University of the Republic

Alexander Goncharov

Alexander Goncharov

Yale University

Massimiliano Di Penta

Massimiliano Di Penta

University of Sannio

J. Nathan Kutz

J. Nathan Kutz

University of Washington

Klaus Yvon

Klaus Yvon

University of Geneva

Charlotte Jacobsen

Charlotte Jacobsen

Technical University of Denmark

Zhengguo Zhang

Zhengguo Zhang

South China University of Technology

André M. Almeida

André M. Almeida

University of Lisbon

Walter D. Gubler

Walter D. Gubler

University of California, Davis

Jaime F. Modiano

Jaime F. Modiano

University of Minnesota

James A. Bassham

James A. Bassham

University of California, Berkeley

Peter Achermann

Peter Achermann

University of Zurich

Peter L. Stern

Peter L. Stern

University of Manchester

Roger K. Blashfield

Roger K. Blashfield

Auburn University

Kevin A. Fenton

Kevin A. Fenton

Public Health England

Something went wrong. Please try again later.